Spinifex Pharmaceuticals is a clinical-stage Australian biotechnology company specialising in the development of products for the treatment of pain.
Spinifex at BIO 2012
The Spinifex team will be attending the 2012 BIO International Convention, to be held in Boston from 18-21 June 2012.
Spinifex Pharmaceuticals will be represented at the Victorian stand at the Australian Pavilion no. 3435 at the Boston Convention & Exhibition Center on Monday 18 June, between 9.00-10.00am.
Latest News & Events
27TH MARCH 2013 Spinifex Receives $1.5m in R&D Tax Incentive for Research Activities Related to the Discovery of ... More
30TH JANUARY 2013 Pivotal EMA401 mechanism of action data has now been published in the European Journal of ... More
10TH DECEMBER 2012 Spinifex Initiates Phase 2 Proof-Of-Concept Clinical Trial in Chemotherapy Induced Neuropathy ... More